Home > Insider Trading > Filing (0001179110-15-008099)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1347405	Robert Bowen	C/O Abiomed, Inc 22 Cherry Hill Dr Danvers MA 01923	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.01 Par Value	Disposition	2015-05-15	5,637	$67.65	76,850	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2015-05-15	585	$68.46	76,265	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$15.92	2009-12-22	2018-12-22	100,000	100,000	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	7,500	7,500	Direct
Common Stock	Stock Option (right to buy)	$22.44	2013-05-22	2023-05-22	20,000	20,000	Direct
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2024-05-14	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-12-22	100,000	100,000	Direct
2020-06-03	7,500	7,500	Direct
2023-05-22	20,000	20,000	Direct
2024-05-14	20,000	20,000	Direct

Footnotes

Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
Sale of common stock pursuant to reporting owner's 10b5-1 plan, including for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.0200 and $68.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.0200 and $68.6350. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.